Onco Therapeutics
每年出版 4 期
ISSN 打印: 2694-4642
ISSN 在线: 2694-4650
Indexed in
卷 1, 2010 册 4
DOI: 10.1615/ForumImmunDisTher.v1.i4
Nitric Oxide-Mediated Regulation of Cancer Immune Escape
pp. 231-249
DOI: 10.1615/ForumImmunDisTher.v1.i4.10
Nitric Oxide Donor and Mimetic Molecules in Cancer Chemotherapy and Chemoprevention
pp. 251-279
DOI: 10.1615/ForumImmunDisTher.v1.i4.20
DETANONOate Is a Potent Chemo\ Radio-Sensitizing Agent in Colon and Colorectal Cancers as Assessed in In Vitro and In Vivo Established Tumor Xenografts
pp. 281-295
DOI: 10.1615/ForumImmunDisTher.v1.i4.30
Post-Translational Regulation of Fas/CD95 in Cell Death and Survival: Role of Nitric Oxide
pp. 297-305
DOI: 10.1615/ForumImmunDisTher.v1.i4.40
Toll-like Receptor 2 and 4 in Cancer Immunotherapy: Is Nitric Oxide a Mediator?
pp. 307-315
DOI: 10.1615/ForumImmunDisTher.v1.i4.50
最新一期
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy